温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 5 月 12 日）- 精准肽公司（CSE: BPC）（OTCQB: PNGAF）（以下简称&#34;公司&#34;或&#34;BPC&#34;），一家专注于先进肽配方和递送系统的上市健康公司，今天宣布已于 2026 年 5 月 8 日与混合武术集团有限公司（&#34; MMA&#34;），一家位于澳大利亚新南威尔士州的公司，签署了一份独家战略营销协议（&#34; 战略营销协议&#34;）。
根据战略营销协议，双方建立了独家合作关系，旨在将公司的肽产品营销和销售给 MMA 的订阅用户群。MMA 运营着 全球最大的数字化连接格斗体育生态系统之一，拥有超过 500 万社交媒体粉丝，约 530,000 个用户档案，超过 75,000 名活跃学生和 800 个经过验证的健身房，并将在协议生效之日及战略营销协议有效期内向所有订阅 MMA 平台的个人和实体推广公司的产品。
根据战略营销协议，公司将向 MMA 支付来自 MMA 来源销售的净收入份额。在生效日期后的前十二（12）个月内，来自 MMA 来源销售的净收入将按 50%/50% 的比例在双方之间平分。从生效日期后的第十三（13）个月开始，MMA 来源销售的净收入将按 75% 分配给公司，25% 分配给 MMA。
战略营销协议自 2026 年 5 月 8 日起生效，持续有效，任一方均有权在提前不少于三十（30）天的书面通知下终止协议。在战略营销协议终止或到期后的十二（12）个月内，公司将继续对在协议有效期内由 MMA 推荐的客户的销售进行核算，并支付 MMA 相应的利润分成。
根据战略营销协议销售的所有肽产品将在美国制造，并将符合所有适用的美国监管要求和标准，包括美国食品药品监督管理局及其他适用监管机构设定的标准。
关于精准肽公司
精准肽公司（CSE: BPC）（OTCQB: PNGAF）是一家上市健康公司，正在建立一个高质量肽配方的下一代平台。通过结合科学配方和创新递送技术，公司创造出位于生物技术与可扩展消费者健康交汇处的产品。产品在美国的批准设施中制造，并在北美分销。
欲了解更多信息，请访问：www.precisionpeptidecompany.com
关于混合武术集团有限公司
MMA.INC 在其各类资产中拥有超过 500 万社交媒体粉丝，530,000 个用户档案，75,000 多名活跃学生，18,000 个已发布健身房和 800 个经过验证的健身房，遍布 22 个国家，继续改变武术格局，为其利益相关者提供无与伦比的价值：
<ul>
<li>全球平台：MMA.INC 在 22 个国家运营，将当地健身房与全球社区和客户连接在一个统一的价值网络中。</li>
<li>训练即获报酬：参与训练、直播、教练或支持任何活动，将获得经验值（XP），这些经验值会透明地记录在链上，并可兑换为真实奖励。</li>
<li>统一生态系统：MMA.INC 现有平台资产包括 BJJLink、TrainAlta、Hype 和 MixedMartialArts.com，提供一个涵盖训练、社区、内容和粉丝的完整平台，独一无二。</li>
</ul>
欲了解更多信息，请访问：www.mma.inc
加拿大证券交易所及其市场监管机构（根据加拿大证券交易所政策中的定义）对本公告的充分性或准确性不承担任何责任。
关于前瞻性信息的警示说明
本新闻稿包含适用加拿大证券立法意义上的&#34;前瞻性信息&#34;。前瞻性信息包括但不限于关于协议对公司的预期利益；双方成功实施和执行营销合作关系的能力；MMA 数字平台和订阅用户基础的预期表现；预期收入、净利润和利润分成结果；以及因合作关系预期的销售增长。
前瞻性信息基于公司管理层在其经验和对趋势、当前状况及预期发展的看法的基础上做出的合理假设、估计、分析和意见，以及管理层认为在提供该信息时相关和合理的其他因素。前瞻性信息涉及已知和未知的风险、不确定性及其他因素，这些因素可能导致公司的实际结果、表现或成就与任何未来结果、表现或成就存在重大差异。此类风险和不确定性包括但不限于：任一方未能履行协议下的义务；任一方在提前 30 天通知下终止协议；MMA 有效地向其订阅用户推广公司产品的能力；影响肽产品销售的加拿大、美国或澳大利亚的监管发展；肽行业竞争条件的变化；来自 MMA 来源销售的收入波动；以及一般经济和商业条件。
尽管公司已尝试识别可能导致实际结果与前瞻性信息中所包含的结果存在重大差异的重要因素，但仍可能存在其他因素导致结果未如预期、估计或意图。不能保证这些信息将被证明是准确的，因为实际结果和未来事件可能与这些声明中预期的结果存在重大差异。因此，读者不应对前瞻性信息过度依赖。公司不承担更新任何前瞻性信息的义务，除非根据适用的证券法律。
本新闻稿中包含的前瞻性信息截至本日期发布，公司不承担公开更新或修订任何前瞻性信息的义务，无论是由于新信息、未来事件还是其他原因，除非根据适用的证券法律要求。
<img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8944/297006_2a814184f47e7909_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="200" height="110" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8944/297006_2a814184f47e7909_logo.jpg"/>
要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/297006
<img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/297006/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/297006/375"/>

精准肽公司（The Precision Peptide Company Inc.）宣布与综合格斗集团有限公司（Mixed Martial Arts Group Limited）达成独家战略营销合作伙伴关系。该合作旨在向综合格斗的广泛订阅用户群体推广和销售公司的肽产品，该用户群体包括超过 500 万的社交媒体关注者和全球 800 家认证健身房。来自综合格斗的销售收入将在第一年内按 50/50 的比例分配，之后将变为公司获得 75%，综合格斗获得 25%。该协议自 2026 年 5 月 8 日起生效，并将持续有效，直到任一方提前 30 天通知终止

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the &#34;Company&#34; or &#34;BPC&#34;), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has entered into an Exclusive Strategic Marketing Agreement (the &#34; Strategic Marketing Agreement&#34;) dated May 8, 2026 with Mixed Martial Arts Group Limited (&#34; MMA&#34;), a New South Wales, Australia-based company.
<div class="lb-trans">温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 5 月 12 日）- 精准肽公司（CSE: BPC）（OTCQB: PNGAF）（以下简称&#34;公司&#34;或&#34;BPC&#34;），一家专注于先进肽配方和递送系统的上市健康公司，今天宣布已于 2026 年 5 月 8 日与混合武术集团有限公司（&#34; MMA&#34;），一家位于澳大利亚新南威尔士州的公司，签署了一份独家战略营销协议（&#34; 战略营销协议&#34;）。
</div>Under the Strategic Marketing Agreement, the parties have entered into an exclusive partnership for the purposes of marketing and selling the Company's peptide products to MMA's subscriber base. MMA operates one of the world's largest digitally connected combat sports ecosystems, with over 5 million social media followers, with approximately 530,000 user profiles, more than 75,000 active students and over 800 verified gyms globally and will market the Company's products to all individuals and entities subscribed to MMA's platform as of the effective date and throughout the term of the Strategic Marketing Agreement.
<div class="lb-trans">根据战略营销协议，双方建立了独家合作关系，旨在将公司的肽产品营销和销售给 MMA 的订阅用户群。MMA 运营着 全球最大的数字化连接格斗体育生态系统之一，拥有超过 500 万社交媒体粉丝，约 530,000 个用户档案，超过 75,000 名活跃学生和 800 个经过验证的健身房，并将在协议生效之日及战略营销协议有效期内向所有订阅 MMA 平台的个人和实体推广公司的产品。
</div>Pursuant to the Strategic Marketing Agreement, the Company will pay MMA a share of net revenue derived exclusively from MMA-sourced sales. During the first twelve (12) months following the effective date, net revenue from MMA-sourced sales will be split equally between the parties on a 50%/50% basis. Commencing in the thirteenth (13th) month following the effective date and for the remainder of the term, net revenue from MMA-sourced sales will be distributed 75% to the Company and 25% to MMA.
<div class="lb-trans">根据战略营销协议，公司将向 MMA 支付来自 MMA 来源销售的净收入份额。在生效日期后的前十二（12）个月内，来自 MMA 来源销售的净收入将按 50%/50% 的比例在双方之间平分。从生效日期后的第十三（13）个月开始，MMA 来源销售的净收入将按 75% 分配给公司，25% 分配给 MMA。
</div>The Strategic Marketing Agreement commences on May 8, 2026 and continues until terminated, with either party having the right to terminate for any reason upon no less than thirty (30) days' prior written notice. For a period of twelve (12) months following termination or expiration of the Strategic Marketing Agreement, the Company will continue to account for and pay MMA's applicable profit share on sales to customers referred by MMA during the term.
<div class="lb-trans">战略营销协议自 2026 年 5 月 8 日起生效，持续有效，任一方均有权在提前不少于三十（30）天的书面通知下终止协议。在战略营销协议终止或到期后的十二（12）个月内，公司将继续对在协议有效期内由 MMA 推荐的客户的销售进行核算，并支付 MMA 相应的利润分成。
</div>All peptide products sold under the Strategic Marketing Agreement will be manufactured in the United States of America and will comply with all applicable U.S. regulatory requirements and standards, including those set by the U.S. Food and Drug Administration and any other applicable regulatory authority.
<div class="lb-trans">根据战略营销协议销售的所有肽产品将在美国制造，并将符合所有适用的美国监管要求和标准，包括美国食品药品监督管理局及其他适用监管机构设定的标准。
</div>About The Precision Peptide Company
<div class="lb-trans">关于精准肽公司
</div>The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the Company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.
<div class="lb-trans">精准肽公司（CSE: BPC）（OTCQB: PNGAF）是一家上市健康公司，正在建立一个高质量肽配方的下一代平台。通过结合科学配方和创新递送技术，公司创造出位于生物技术与可扩展消费者健康交汇处的产品。产品在美国的批准设施中制造，并在北美分销。
</div>For more information, visit: www.precisionpeptidecompany.com
<div class="lb-trans">欲了解更多信息，请访问：www.precisionpeptidecompany.com
</div>About Mixed Martial Arts Group Limited
<div class="lb-trans">关于混合武术集团有限公司
</div>With over 5 million social media followers, 530,000 user profiles, 75,000+ active students, 18,000 published gyms and 800 verified gyms across 22 countries across its various assets, MMA.INC continues to transform the martial arts landscape and deliver unparalleled value to its stakeholders:
<div class="lb-trans">MMA.INC 在其各类资产中拥有超过 500 万社交媒体粉丝，530,000 个用户档案，75,000 多名活跃学生，18,000 个已发布健身房和 800 个经过验证的健身房，遍布 22 个国家，继续改变武术格局，为其利益相关者提供无与伦比的价值：
</div><ul>
<li>A Global Platform: Operating across 22 countries, MMA.INC connects local gyms with global communities and customers in a single, connected network of value.</li>
<li>Get Paid to Train: Engaging in training, streaming, coaching or simply supporting any activity, will earn Experience Points (XP), which is transparently logged on chain and can be redeemed for real rewards.</li>
<li>One Unified Ecosystem: With existing platform assets including BJJLink, TrainAlta, Hype and MixedMartialArts.com, MMA.INC provides a complete platform that covers training, community, content and fandom like no other.</li>
</ul>
<div class="lb-trans"><ul>
<li>全球平台：MMA.INC 在 22 个国家运营，将当地健身房与全球社区和客户连接在一个统一的价值网络中。</li>
<li>训练即获报酬：参与训练、直播、教练或支持任何活动，将获得经验值（XP），这些经验值会透明地记录在链上，并可兑换为真实奖励。</li>
<li>统一生态系统：MMA.INC 现有平台资产包括 BJJLink、TrainAlta、Hype 和 MixedMartialArts.com，提供一个涵盖训练、社区、内容和粉丝的完整平台，独一无二。</li>
</ul>
</div>For more information, visit www.mma.inc
<div class="lb-trans">欲了解更多信息，请访问：www.mma.inc
</div>Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
<div class="lb-trans">加拿大证券交易所及其市场监管机构（根据加拿大证券交易所政策中的定义）对本公告的充分性或准确性不承担任何责任。
</div>Cautionary Note Regarding Forward-Looking Information
<div class="lb-trans">关于前瞻性信息的警示说明
</div>This news release contains &#34;forward-looking information&#34; within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements regarding the anticipated benefits of the Agreement to the Company; the parties' ability to successfully implement and execute the marketing partnership; the expected performance of MMA's digital platform and subscriber base; anticipated revenue, net profit, and profit-sharing outcomes; and the expected growth of sales attributable to the partnership.
<div class="lb-trans">本新闻稿包含适用加拿大证券立法意义上的&#34;前瞻性信息&#34;。前瞻性信息包括但不限于关于协议对公司的预期利益；双方成功实施和执行营销合作关系的能力；MMA 数字平台和订阅用户基础的预期表现；预期收入、净利润和利润分成结果；以及因合作关系预期的销售增长。
</div>Forward-looking information is based on the reasonable assumptions, estimates, analysis, and opinions of the Company's management made in light of its experience and perception of trends, current conditions, and expected developments, as well as other factors that management believes to be relevant and reasonable at the date that such information is provided. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking information. Such risks and uncertainties include, without limitation: the failure of either party to perform its obligations under the Agreement; termination of the Agreement by either party on 30 days' notice; the ability of MMA to effectively market the Company's products to its subscriber base; regulatory developments in Canada, the United States, or Australia affecting the sale of peptide products; changes in competitive conditions in the peptide industry; fluctuations in revenue derived from MMA-sourced sales; and general economic and business conditions.
<div class="lb-trans">前瞻性信息基于公司管理层在其经验和对趋势、当前状况及预期发展的看法的基础上做出的合理假设、估计、分析和意见，以及管理层认为在提供该信息时相关和合理的其他因素。前瞻性信息涉及已知和未知的风险、不确定性及其他因素，这些因素可能导致公司的实际结果、表现或成就与任何未来结果、表现或成就存在重大差异。此类风险和不确定性包括但不限于：任一方未能履行协议下的义务；任一方在提前 30 天通知下终止协议；MMA 有效地向其订阅用户推广公司产品的能力；影响肽产品销售的加拿大、美国或澳大利亚的监管发展；肽行业竞争条件的变化；来自 MMA 来源销售的收入波动；以及一般经济和商业条件。
</div>Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated, or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
<div class="lb-trans">尽管公司已尝试识别可能导致实际结果与前瞻性信息中所包含的结果存在重大差异的重要因素，但仍可能存在其他因素导致结果未如预期、估计或意图。不能保证这些信息将被证明是准确的，因为实际结果和未来事件可能与这些声明中预期的结果存在重大差异。因此，读者不应对前瞻性信息过度依赖。公司不承担更新任何前瞻性信息的义务，除非根据适用的证券法律。
</div>The forward-looking information contained in this news release is made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
<div class="lb-trans">本新闻稿中包含的前瞻性信息截至本日期发布，公司不承担公开更新或修订任何前瞻性信息的义务，无论是由于新信息、未来事件还是其他原因，除非根据适用的证券法律要求。
</div><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8944/297006_2a814184f47e7909_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/8944/297006_2a814184f47e7909_logo.jpg"/>
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297006
<div class="lb-trans">要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/297006
</div><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/297006/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/297006/375"/>

精密肽公司宣布与 Mixed Martial Arts Group Limited 达成独家战略营销合作伙伴关系 | PNGAF 股票新闻